Bioanalysis of a double blind, placebo-controlled clinical phase 2 study of drisapersen for the treatment of boys suffering from Duchenne muscular dystrophy and comparison to clinical outcome results

Category Primary study
ConferenceNeuromuscular Disorders
Year 2013
This article has no abstract
Epistemonikos ID: d964afc38d8732f4843e5a5b08a3c94247379620
First added on: Feb 07, 2025